PAIYY Aesthetic Medical International Holdings Group Ltd IFRS Annual reports only
Services-Specialty Outpatient Facilities, NEC · OTC · SEC CIK 1757143 · Reporting currency CNY · Fiscal year ends 12/31
Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: CNY | FY20242024-12-31 | FY20232023-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | 755.67M | 682.59M |
| Cost of revenue | 417.88M | 360.54M |
| Gross profit | 337.79M | 322.05M |
| SG&A expense | 100.78M | 138.60M |
| Interest expense | 8.72M | 14.47M |
| Pretax income | -1.35M | -55.06M |
| Income tax | 23.73M | -15.14M |
| Net income | -19.95M | -37.43M |
| EPS (basic) | -0.14 | -0.28 |
| EPS (diluted) | -0.14 | -0.28 |
| Weighted avg. shares (diluted) | 143.50M | 131.66M |
| Balance sheet | ||
| Cash & equivalents | 42.84M | 62.34M |
| Receivables | 18.38M | 21.66M |
| Inventory | 14.91M | 15.58M |
| PP&E, netmay include right-of-use assets (IFRS) | 266.24M | 304.22M |
| Total assets | 486.22M | 560.66M |
| Current liabilities | 402.04M | 411.38M |
| Short-term debt | 72.22M | 73.93M |
| Long-term debt | 13.72M | 31.41M |
| Total debt | 85.94M | 105.34M |
| Total liabilities | 476.88M | 527.03M |
| Shareholders' equity | 30.46M | 48.89M |
| Net debt | 43.10M | 43.01M |
| Cash flow statement | ||
| Operating cash flow | 79.67M | 74.29M |
| Capital expenditure | 30.60M | 55.24M |
| Free cash flow | 49.07M | 19.04M |
| Investing cash flow | -30.32M | -52.25M |
| Financing cash flow | -68.55M | 29.06M |
| Depreciation & amortization | 65.96M | 65.90M |
| Stock-based compensation | 0 | 7.51M |
| Share buybacks | 2.02M | — |
Free plan shows the latest 2 periods; Pro shows all 8 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· Amounts are in the company's reporting currency, CNY, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.